Complete Filing Data
Tenaya Therapeutics, Inc. reported Stockholders Equity of $123.27 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Tenaya Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$90.6M | -$111.1M | -$124.1M | -$123.7M | -$72.7M | -$38.4M |
| Research And Development Expense | $68.6M | $86.7M | $98.0M | $94.5M | $54.4M | $31.1M |
| Operating Income Loss | -$93.3M | -$115.9M | -$131.2M | -$125.6M | -$72.8M | -$38.9M |
| Operating Expenses | $93.3M | $115.9M | $131.2M | $125.6M | $72.8M | $38.9M |
| Nonoperating Income Expense | $2.7M | $4.8M | $7.1M | $2.0M | $85.0K | $517.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$90.6M | -$111.1M | -$124.1M | -$123.7M | -$72.7M | -$38.4M |
| General And Administrative Expense | $24.7M | $29.2M | $33.2M | $31.1M | $18.4M | $7.8M |
| Other Nonoperating Income Expense | $52.0K | $82.0K | $53.0K | $2.0K | -$23.0K | $355.0K |
| Comprehensive Income Net Of Tax | -$90.6M | -$111.0M | -$123.8M | -$123.9M | -$72.9M | -$38.4M |
| Other Comprehensive Income Loss Net Of Tax | -$28.0K | $134.0K | $272.0K | -$237.0K | -$141.0K | |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$28.0K | $134.0K | $272.0K | -$237.0K | -$141.0K | |
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$20.3M | -$23.3M | -$26.9M | -$25.6M | -$29.4M | -$32.2M | -$29.1M | -$33.3M | -$31.7M | -$30.7M | -$28.4M | -$31.1M | -$18.3M | -$15.2M | -$13.1M | -$10.3M | -$8.7M | -$9.1M |
| Research And Development Expense | $15.4M | $17.4M | $21.1M | $20.4M | $22.6M | $25.1M | $23.1M | $26.5M | $25.6M | $23.8M | $20.9M | $24.2M | $12.9M | $10.9M | $9.6M | $8.5M | $7.0M | |
| Operating Income Loss | -$20.9M | -$24.1M | -$27.5M | -$26.7M | -$30.8M | -$33.8M | -$30.9M | -$35.1M | -$33.7M | -$31.3M | -$28.6M | -$31.2M | -$18.3M | -$15.2M | -$13.1M | -$10.5M | -$8.9M | |
| Operating Expenses | $20.9M | $24.1M | $27.5M | $26.7M | $30.8M | $33.8M | $30.9M | $35.1M | $33.7M | $31.3M | $28.6M | $31.2M | $18.3M | $15.2M | $13.1M | $10.5M | $8.9M | |
| Nonoperating Income Expense | $661.0K | $799.0K | $674.0K | $1.1M | $1.4M | $1.5M | $1.8M | $1.8M | $2.0M | $602.0K | $222.0K | $98.0K | $38.0K | $27.0K | $7.0K | $157.0K | $141.0K | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$20.3M | -$23.3M | -$26.9M | -$25.6M | -$29.4M | -$32.2M | -$29.1M | -$33.3M | -$31.7M | -$30.7M | -$28.4M | -$31.1M | -$18.3M | -$15.2M | -$13.1M | -$10.3M | -$8.7M | |
| General And Administrative Expense | $5.6M | $6.7M | $6.5M | $6.4M | $8.2M | $8.7M | $7.8M | $8.6M | $8.1M | $7.5M | $7.7M | $7.0M | $5.4M | $4.3M | $3.5M | $2.0M | $1.9M | |
| Other Nonoperating Income Expense | $3.0K | -$16.0K | $39.0K | -$3.0K | -$1.0K | $82.0K | $1.0K | -$2.0K | $13.0K | $6.0K | -$1.0K | $15.0K | $18.0K | -$2.0K | -$1.0K | $180.0K | ||
| Comprehensive Income Net Of Tax | -$20.3M | -$23.3M | -$26.9M | -$25.5M | -$29.4M | -$32.2M | -$29.1M | -$33.5M | -$31.5M | -$30.7M | -$28.5M | -$31.5M | -$18.3M | -$15.2M | -$13.1M | -$10.3M | ||
| Other Comprehensive Income Loss Net Of Tax | $1.0K | $9.0K | -$38.0K | $143.0K | $53.0K | -$14.0K | $72.0K | -$213.0K | $258.0K | -$28.0K | -$108.0K | -$490.0K | -$23.0K | |||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $1.0K | $9.0K | -$38.0K | $143.0K | $53.0K | -$14.0K | $72.0K | -$213.0K | $258.0K | -$28.0K | -$108.0K | -$490.0K | -$23.0K | |||||
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $123.3M | $92.9M | $139.4M | $243.4M | $278.5M | -$81.3M | -$43.7M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $101.0M | $4.7M | $46.4M | $95.7M | $38.7M | $129.1M | $24.3M |
| Cash And Cash Equivalents At Carrying Value | $100.5M | $4.3M | $45.7M | $95.3M | $38.1M | $128.5M | |
| Restricted Cash Noncurrent | $419.0K | $419.0K | $682.0K | $399.0K | $547.0K | $547.0K | |
| Retained Earnings Accumulated Deficit | -$605.0M | -$514.4M | -$403.3M | -$279.2M | -$155.5M | -$82.8M | |
| Property Plant And Equipment Net | $27.7M | $35.9M | $43.3M | $51.0M | $43.0M | $17.2M | |
| Prepaid Expense And Other Assets Current | $5.0M | $5.9M | $6.9M | $7.2M | $4.1M | $1.4M | |
| Other Liabilities Noncurrent | $410.0K | $281.0K | $253.0K | $228.0K | $182.0K | $19.0K | |
| Other Assets Noncurrent | $4.2M | $4.8M | $5.7M | $4.8M | $4.1M | $465.0K | |
| Liabilities Current | $15.4M | $16.0M | $22.7M | $24.2M | $21.8M | $5.0M | |
| Liabilities And Stockholders Equity | $146.9M | $119.9M | $170.5M | $278.9M | $314.2M | $148.2M | |
| Liabilities | $23.7M | $27.1M | $31.1M | $35.6M | $35.7M | $8.7M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $96.2M | -$41.6M | -$49.3M | $57.0M | -$90.4M | $104.8M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $101.0M | $4.7M | $46.4M | $95.7M | $38.7M | $129.1M | |
| Assets Current | $105.6M | $67.4M | $111.6M | $193.8M | $255.4M | $130.0M | |
| Assets | $146.9M | $119.9M | $170.5M | $278.9M | $314.2M | $148.2M | |
| Accrued Liabilities Current | $8.8M | $8.0M | $12.8M | $10.7M | $9.1M | $3.2M | |
| Accounts Payable Current | $3.6M | $5.2M | $5.6M | $9.6M | $10.7M | $1.0M | |
| Operating Lease Right Of Use Asset | $9.4M | $11.9M | $10.0M | $11.7M | $11.7M | ||
| Operating Lease Liability Noncurrent | $7.8M | $10.8M | $8.1M | $11.1M | $13.7M | ||
| Operating Lease Liability Current | $3.0M | $2.8M | $4.3M | $4.0M | $2.0M | ||
| Common Stock Value | $21.0K | $8.0K | $7.0K | $7.0K | $4.0K | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $0.00 | $28.0K | -$106.0K | -$378.0K | -$141.0K | ||
| Operating Lease Right Of Use Asset Amortization Expense | $2.5M | $3.4M | $3.1M | $2.2M | $1.1M | ||
| Amortization Of Premium On Marketable Securities | $411.0K | -$184.0K | $315.0K | -$307.0K | $131.0K | ||
| Short Term Investments | $57.1M | $59.0M | $91.3M | $213.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $82.9M | $99.8M | $119.4M | $112.6M | $134.0M | $158.2M | $164.9M | $189.9M | $215.4M | $196.3M | $223.9M | $249.1M | $303.7M | -$108.5M | -$93.9M | -$71.2M | -$61.2M | -$52.6M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $56.7M | $63.1M | $54.2M | $8.7M | $58.6M | $60.0M | $82.8M | $76.0M | $72.9M | $34.9M | $31.4M | $26.4M | $117.6M | $112.4M | $129.0M | $61.7M | $40.7M | |
| Cash And Cash Equivalents At Carrying Value | $56.3M | $62.7M | $53.8M | $8.2M | $58.1M | $59.3M | $82.2M | $75.6M | $72.5M | $34.5M | $31.0M | $26.0M | $117.1M | $111.9M | $128.4M | $61.3M | $40.3M | |
| Restricted Cash Noncurrent | $419.0K | $419.0K | $419.0K | $419.0K | $419.0K | $682.0K | $682.0K | $420.0K | $399.0K | $399.0K | $399.0K | $399.0K | $547.0K | $547.0K | $547.0K | $399.0K | $399.0K | |
| Retained Earnings Accumulated Deficit | -$584.8M | -$564.6M | -$541.3M | -$490.6M | -$464.9M | -$435.5M | -$373.3M | -$344.2M | -$310.9M | -$245.7M | -$215.0M | -$186.6M | -$129.4M | -$111.1M | ||||
| Property Plant And Equipment Net | $29.4M | $31.3M | $33.4M | $37.8M | $39.4M | $41.4M | $45.1M | $47.0M | $49.4M | $52.2M | $53.0M | $49.4M | $30.9M | $24.9M | ||||
| Prepaid Expense And Other Assets Current | $4.9M | $4.2M | $6.3M | $5.9M | $5.7M | $6.5M | $5.1M | $6.4M | $6.8M | $7.6M | $4.8M | $3.3M | $4.4M | $1.3M | ||||
| Other Liabilities Noncurrent | $301.0K | $293.0K | $287.0K | $276.0K | $266.0K | $259.0K | $246.0K | $240.0K | $234.0K | $223.0K | $217.0K | $212.0K | $96.0K | $3.0K | ||||
| Other Assets Noncurrent | $4.2M | $4.3M | $4.8M | $4.9M | $5.1M | $5.6M | $5.7M | $5.5M | $4.6M | $4.7M | $3.7M | $6.6M | $3.5M | $5.9M | ||||
| Liabilities Current | $13.2M | $12.7M | $14.2M | $16.2M | $16.7M | $19.2M | $19.4M | $20.9M | $19.3M | $17.7M | $18.7M | $19.1M | $13.7M | $9.8M | ||||
| Liabilities And Stockholders Equity | $105.0M | $122.2M | $144.0M | $140.6M | $163.2M | $184.9M | $193.4M | $220.8M | $245.3M | $226.3M | $255.9M | $281.5M | $331.8M | $156.9M | ||||
| Liabilities | $22.1M | $22.3M | $24.6M | $28.0M | $29.2M | $26.7M | $28.5M | $30.8M | $29.9M | $30.0M | $32.1M | $32.4M | $28.1M | $24.7M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $49.4M | $13.6M | -$22.7M | -$12.3M | -$97.0K | |||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $56.7M | $63.1M | $54.2M | $8.7M | $58.6M | $60.0M | $82.8M | $76.0M | $72.9M | $34.9M | $31.4M | $26.4M | $117.6M | $112.4M | $129.0M | $61.7M | $40.7M | |
| Assets Current | $61.2M | $75.9M | $94.5M | $85.3M | $105.0M | $128.7M | $126.8M | $138.9M | $154.6M | $157.1M | $185.7M | $213.8M | $284.8M | $113.2M | ||||
| Assets | $105.0M | $122.2M | $144.0M | $140.6M | $163.2M | $184.9M | $193.4M | $220.8M | $245.3M | $226.3M | $255.9M | $281.5M | $331.8M | $156.9M | ||||
| Accrued Liabilities Current | $7.4M | $6.5M | $6.3M | $7.3M | $9.0M | $8.4M | $10.3M | $9.0M | $8.1M | $8.4M | $9.5M | $8.1M | $5.6M | $3.1M | ||||
| Accounts Payable Current | $2.8M | $3.3M | $5.1M | $5.8M | $4.3M | $6.7M | $5.9M | $8.5M | $7.4M | $5.3M | $5.3M | $8.9M | $6.2M | $5.0M | ||||
| Operating Lease Right Of Use Asset | $10.1M | $10.7M | $11.3M | $12.6M | $13.7M | $9.2M | $9.3M | $10.1M | $10.9M | $12.4M | $13.1M | $11.4M | $12.0M | $12.3M | ||||
| Operating Lease Liability Noncurrent | $8.6M | $9.4M | $10.1M | $11.5M | $12.2M | $7.3M | $8.9M | $9.7M | $10.4M | $12.0M | $13.1M | $13.1M | $14.3M | $14.9M | ||||
| Operating Lease Liability Current | $2.9M | $2.8M | $2.8M | $3.0M | $3.4M | $4.1M | $3.2M | $3.4M | $3.7M | $4.0M | $3.9M | $2.1M | $1.9M | $1.6M | ||||
| Common Stock Value | $16.0K | $16.0K | $16.0K | $8.0K | $8.0K | $8.0K | $7.0K | $7.0K | $7.0K | $4.0K | $4.0K | $4.0K | $4.0K | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$1.0K | -$10.0K | $76.0K | -$67.0K | -$120.0K | -$261.0K | -$333.0K | -$120.0K | -$767.0K | -$739.0K | -$631.0K | -$23.0K | ||||||
| Operating Lease Right Of Use Asset Amortization Expense | $596.0K | $802.0K | $754.0K | $332.0K | $171.0K | |||||||||||||
| Amortization Of Premium On Marketable Securities | $31.0K | -$74.0K | -$567.0K | $143.0K | ||||||||||||||
| Short Term Investments | $9.0M | $34.4M | $71.2M | $41.2M | $62.9M | $39.6M | $56.9M | $75.3M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $13.0M | $16.5M | $15.3M | $11.5M | $3.0M | $741.0K |
| Payments To Acquire Property Plant And Equipment | $618.0K | $1.0M | $1.2M | $20.6M | $25.1M | $9.8M |
| Net Cash Provided By Used In Operating Activities | -$68.3M | -$90.5M | -$102.1M | -$104.4M | -$60.8M | -$35.4M |
| Net Cash Provided By Used In Investing Activities | $56.1M | $1.1M | $48.7M | $83.7M | -$238.6M | -$7.0M |
| Net Cash Provided By Used In Financing Activities | $108.4M | $47.7M | $4.0M | $77.8M | $209.0M | $147.3M |
| Increase Decrease In Prepaid Expense And Other Current Assets | -$547.0K | -$857.0K | -$101.0K | $2.9M | $2.7M | $312.0K |
| Increase Decrease In Accrued Liabilities And Other Current Liabilities | $532.0K | -$4.7M | $2.3M | $4.3M | $3.3M | $925.0K |
| Increase Decrease In Accounts Payable | -$1.4M | -$581.0K | -$3.3M | $1.7M | $8.6M | $142.0K |
| Depreciation Depletion And Amortization | $8.4M | $8.5M | $8.7M | $6.5M | $3.0M | $2.5M |
| Increase Decrease In Other Noncurrent Assets | -$571.0K | -$656.0K | $601.0K | $815.0K | $3.1M | |
| Increase Decrease In Operating Lease Liability | -$2.8M | -$4.1M | -$4.1M | -$3.1M | -$1.5M | |
| Proceeds From Sale And Maturity Of Marketable Securities | $45.7M | $81.2M | $106.6M | $244.8M | $2.8M | |
| Payments To Acquire Marketable Securities | $0.00 | $87.1M | $56.6M | $140.5M | $213.4M | |
| Proceeds From Exercise Of Stock Options And Employee Stock Purchase Plan | $139.0K | $979.0K | $682.0K | $380.0K | $374.0K | |
| Payments For Proceeds From Other Investing Activities | $0.00 | -$17.0K | $25.0K | -$8.0K | ||
| Increase Decrease In Other Noncurrent Liabilities | $102.0K | $0.00 | $1.0K | -$1.0K | $163.0K | -$34.0K |
| Payments Of Stock Issuance Costs | $501.0K | |||||
| Proceeds From Exercises Of Pre Funded Warrants | $0.00 | $8.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|
| Share Based Compensation | $3.7M | $4.2M | $3.5M | $2.1M | $432.0K |
| Payments To Acquire Property Plant And Equipment | $383.0K | $564.0K | $629.0K | $8.6M | $4.3M |
| Net Cash Provided By Used In Operating Activities | -$23.1M | -$28.7M | -$30.3M | -$28.8M | -$15.8M |
| Net Cash Provided By Used In Investing Activities | $22.3M | -$4.5M | $8.1M | $16.4M | -$4.3M |
| Net Cash Provided By Used In Financing Activities | $50.3M | $46.8M | -$501.0K | $15.0K | $20.0M |
| Increase Decrease In Prepaid Expense And Other Current Assets | $460.0K | -$447.0K | -$366.0K | -$732.0K | -$118.0K |
| Increase Decrease In Accrued Liabilities And Other Current Liabilities | -$1.9M | -$4.4M | -$2.7M | $318.0K | -$1.0M |
| Increase Decrease In Accounts Payable | -$379.0K | $1.3M | -$1.3M | -$1.8M | $618.0K |
| Depreciation Depletion And Amortization | $2.7M | $2.2M | $2.1M | $966.0K | $689.0K |
| Increase Decrease In Other Noncurrent Assets | -$4.0K | -$50.0K | -$163.0K | -$25.0K | $3.3M |
| Increase Decrease In Operating Lease Liability | -$697.0K | -$1.1M | -$979.0K | -$533.0K | -$384.0K |
| Proceeds From Sale And Maturity Of Marketable Securities | $11.7M | $19.7M | $34.5M | $68.2M | |
| Payments To Acquire Marketable Securities | $23.6M | $25.8M | $43.2M | ||
| Proceeds From Exercise Of Stock Options And Employee Stock Purchase Plan | $8.0K | $15.0K | |||
| Payments For Proceeds From Other Investing Activities | -$1.0K | $12.0K | |||
| Increase Decrease In Other Noncurrent Liabilities | $2.0K | ||||
| Payments Of Stock Issuance Costs | $0.00 | $501.0K | |||
| Proceeds From Exercises Of Pre Funded Warrants | $1.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.59 | -$1.31 | -$1.68 | -$2.76 | -$4.10 | -$39.50 |
| Weighted Average Number Of Shares Outstanding Basic | 153.0M | 84.8M | 73.8M | 44.8M | 17.7M | |
| Weighted Average Number Of Diluted Shares Outstanding | 153.0M | 84.8M | 73.8M | 44.8M | 17.7M | |
| Earnings Per Share Basic | $-0.59 | $-1.31 | $-1.68 | $-2.76 | $-4.10 | |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 17.7M | 972.1K | ||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 0.00 |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 216.8M | 86.5M | 68.3M | 66.9M | 41.3M | 1.2M |
| Common Stock Shares Issued | 216.8M | 86.5M | 68.3M | 66.9M | 41.3M | 1.2M |
| Common Stock Shares Authorized | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 30.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.12 | -$0.14 | -$0.24 | -$0.30 | -$0.34 | -$0.40 | -$0.39 | -$0.45 | -$0.43 | -$0.74 | -$0.69 | -$0.75 | -$0.68 | -$13.26 | -$11.93 | -$10.29 | -$9.21 |
| Weighted Average Number Of Shares Outstanding Basic | 163.3M | 162.8M | 109.9M | 86.2M | 85.7M | 81.0M | 73.9M | 73.4M | 73.1M | 41.4M | 41.3M | 41.3M | 26.9M | ||||
| Weighted Average Number Of Diluted Shares Outstanding | 163.3M | 162.8M | 109.9M | 86.2M | 85.7M | 81.0M | 73.9M | 73.4M | 73.1M | 41.4M | 41.3M | 41.3M | 26.9M | ||||
| Earnings Per Share Basic | $-0.12 | $-0.14 | $-0.24 | $-0.30 | $-0.34 | $-0.40 | $-0.39 | $-0.45 | $-0.43 | $-0.74 | $-0.69 | $-0.75 | $-0.68 | ||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 41.3M | 41.3M | 26.9M | 1.1M | 1.1M | 1.0M | 948.4K | ||||||||||
| Preferred Stock Shares Outstanding | |||||||||||||||||
| Preferred Stock Shares Issued | |||||||||||||||||
| Preferred Stock Shares Authorized | |||||||||||||||||
| Preferred Stock Par Or Stated Value Per Share | |||||||||||||||||
| Common Stock Shares Outstanding | |||||||||||||||||
| Common Stock Shares Issued | |||||||||||||||||
| Common Stock Shares Authorized |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $13.0M | $16.5M | $15.3M | $11.5M | $3.0M | $741.0K |
| Investment Income Interest | $2.7M | $4.7M | $7.1M | $2.0M | $108.0K | $87.0K |
| Vesting Of Early Exercised Stock Options | $1.0K | $19.0K | $32.0K | $45.0K | ||
| Additional Paid In Capital | $728.3M | $607.2M | $542.8M | $522.9M | $434.2M | $1.6M |
| Capital Expenditures Incurred But Not Yet Paid | $60.0K | $358.0K | $249.0K | $549.0K | $4.1M | $364.0K |
| Stock Issued During Period Value Stock Options Exercised | $358.0K | $34.0K | ||||
| Other Noncash Income Expense | -$423.0K | -$383.0K | -$217.0K | -$217.0K | -$61.0K | |
| Stock Issued During Period Value Employee Stock Purchase Plan | $112.0K | $866.0K | $653.0K | $329.0K | ||
| Stock Issued During Period Value Stock Options Exercised And Vesting Of Restricted Stock Units | $27.0K | $113.0K | $29.0K | $51.0K | ||
| Stock Issued During Period Value Conversion Of Convertible Securities | $8.0K | $240.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $2.9M | $3.6M | $3.7M | $3.9M | $4.6M | $4.2M | $4.0M | $3.8M | $3.5M | $3.2M | $3.0M | $2.1M | $968.0K | $502.0K | $432.0K | $198.0K | $185.0K | $154.0K |
| Investment Income Interest | $658.0K | $815.0K | $635.0K | $1.1M | $1.4M | $1.5M | $1.8M | $1.8M | $2.0M | $596.0K | $222.0K | $99.0K | $23.0K | $9.0K | $9.0K | $7.0K | $18.0K | |
| Vesting Of Early Exercised Stock Options | $1.0K | $5.0K | $5.0K | $6.0K | $8.0K | $9.0K | $9.0K | $11.0K | $11.0K | $11.0K | ||||||||
| Additional Paid In Capital | $667.7M | $664.4M | $660.7M | $603.1M | $599.0M | $593.8M | $538.5M | $534.5M | $526.5M | $442.8M | $439.6M | $436.3M | $433.1M | $2.6M | ||||
| Capital Expenditures Incurred But Not Yet Paid | $138.0K | $7.0K | $370.0K | $5.3M | $452.0K | |||||||||||||
| Stock Issued During Period Value Stock Options Exercised | $29.0K | $28.0K | $17.0K | $268.0K | $31.0K | $29.0K | $12.0K | $2.0K | $3.0K | |||||||||
| Other Noncash Income Expense | -$168.0K | -$100.0K | -$52.0K | |||||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $70.0K | $554.0K | $282.0K | $230.0K | ||||||||||||||
| Stock Issued During Period Value Stock Options Exercised And Vesting Of Restricted Stock Units | $24.0K | $14.0K | $30.0K | $11.0K | $6.0K | |||||||||||||
| Stock Issued During Period Value Conversion Of Convertible Securities | $1.0K | $240.7M |
Most recent annual filing with the SEC: March 11, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.